Skip to main content
PMC home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2003 Jul;18(2):71–79. doi: 10.1007/BF02867370

Cardioprotective activity of synthetic guggulsterone (E and Z-isomers) in isoproterenol induced myocardial ischemia in rats: A comparative study

Ramesh Chander 1,✉, Farhan Rizvi 1, A K Khanna 1, Ram Pratap 2
PMCID: PMC3453889  PMID: 23105395

Abstract

Guggulsterone, a mixture of cis (E) and trans (Z) isomers (7∶3 w/w) was synthesized from 16-DPA. The isomers were separated by column chromatography and evaluated for cardioprotective and antioxidant activities. Myocardial necrosis induced by isoproterenol in rats caused marked increase in serum creatine phosphokinase and glutamate pyruvate transaminase. Simultaneously in ischemic heart, phospholipase, xanthine oxidase and lipid peroxides were enhanced following depletion of glycogen, phospholipids and cholesterol. Treatment with guggulsterone and its both isomers at the dose of 50 mg/kg po., significantly protected cardiac damage as assessed by the reversal of blood and heart biochemical parameters in ischemic rats. The cardioprotective activity of guggulsterone and of both the isomers were compared with that of gemfibrozil at the same doses. Guggulsterone and both the isomers at tested concentrations (5–20mM) inhibited oxidative degradation of lipids in human low-density lipoprotein and rat liver microsomes induced by metal ionsin vitro. The drug counteracted against the generation of superoxide anions (O2) and hydroxyl radicals (OH−) in non-enzymic test systems. It is suggested that cardioprotective and antioxidant activities of synthetic guggulsterone and guggulsterone obtained from gum resinCommiphora mukul that contains isomers E & Z in the ratio of 46∶54w/w are the same.

Key Words: Cis and trans-guggulsterone, cardiprotective activity, antioxidant property, Isoproterenol cardiac

Full Text

The Full Text of this article is available as a PDF (593.5 KB).

References

  • 1.Nadkarni A.K. Indian Materia medica. Bombay, India: Popular Book Dept; 1954. [Google Scholar]
  • 2.Satyavati G.V. Effect of an indigenous drug on disorders of lipid metabolism with special references to atherosclerosis and obesity (medoroga) Varanasi: Banaras Hindu University; 1966. [Google Scholar]
  • 3.Nityanand S., Kapoor N.K. Cholesterol lowering activity of the various fractions of guggul. Ind. J. Exp. Biol. 1973;11:395–395. [PubMed] [Google Scholar]
  • 4.Dev Sukh. A modern look at an age old Ayurvedic drug Guggul. Science Age. 1987;5:13–13. [Google Scholar]
  • 5.Satyavati G.V. economic and medicinal plant research, vol. v Plants and Traditional Medicine. New York: Academic Press; 1991. Guggulipid: A promisinghypolipidemic agent from gum guggul (Commiphora wightii) pp. 47–82. [Google Scholar]
  • 6.Kuppuranjan K., Rajagopalan S.S., Koteswara Rao, T., Sitaraman R. Effect of guggulu (Commiphora mukul Engl) on serum lipids in obese, hypercholesterolemic and hyperlipemic cases. J. Assoc. Physicians India. 1978;26:367–367. [PubMed] [Google Scholar]
  • 7.Tripathi S.N., Shastri V.V.S., Satyavati G.V. Experimental and clinical studies on the effect of guggulu (Commiphora mukul) in hyperlipemia and thrombosis. Ind. J. Med. Res. 1968;2:10–10. [Google Scholar]
  • 8.Baldav V.S., Sharma R.C., Ranka P.C., Chittera M. D. Effect of commiphora mukul (guggul) on fibrinolytic activity and platelet aggregationin coronary artery disease. Rajasthan Med. J. 1980;19:84–84. [Google Scholar]
  • 9.Bordia A., Chuttani S.K. Effect of gum guggulu on fibrinolysis and platelet adhesiveness in coronary heart disease. Ind. J. Med. Res. 1979;70:992–992. [PubMed] [Google Scholar]
  • 10.Satyavati G.V., Dwarkanath C., Tripathi S.N. Experimental studies on the hypocholesterrolemic effect of Commiphora mukul. Engl (Guggul) Ind. J. Med. Res. 1969;57:1950–1950. [PubMed] [Google Scholar]
  • 11.Singh A.K., Prasad G.C., Tripathi S.N. In vitro studies on thyrogenic effect of commiphora mukul (guggulu) Ancient Sci. Life. 1982;2:23–23. [PMC free article] [PubMed] [Google Scholar]
  • 12.Chander R., Khanna A. K., Kapoor N.K. Lipid lowering activity of guggulsterone fromCommiphora mukul in hyperlipemic rat. Phytotherapy Res. 1996;10:508–511. doi: 10.1002/(SICI)1099-1573(199609)10:6<508::AID-PTR895>3.0.CO;2-P. [DOI] [Google Scholar]
  • 13.Mester M., Mester L., Nityanand S. Inhibition of platelet aggregation by ‘Guggulu’ steroids. Planta Medica. 1979;37:367–369. doi: 10.1055/s-0028-1097351. [DOI] [PubMed] [Google Scholar]
  • 14.Kaul S., Kapoor N.K. Cardiac sarcolemma enzymes and liver microsomal cytochrome P450 in isoproterenol treated rats. Ind. J. Med. Res. 1989;90:62–68. [PubMed] [Google Scholar]
  • 15.Chander R., Khanna A.K., Pratap R. Antioxidant activity of guggulsterone, the active principle of guggulipid from Commiphora mukul. J. Med. Arom. Plant Sci. 2002;24:370–374. [Google Scholar]
  • 16.Benn W.R., Dodson R.M. The synthesis and stereochemistry of isomeric 16-hydroxy-17 (20) pregnenes. J. Org. Chem. 1964;29:1142–1148. doi: 10.1021/jo01028a035. [DOI] [Google Scholar]
  • 17.Kaul S., Singh V., Kapoor N.K. Protective effect of Colcenol on biochemical changes produced in coronary ligation induced ischemia. Ind. J. Exp. Biol. 1990;28:981–984. [PubMed] [Google Scholar]
  • 18.Bessy O.A., Lowry O.H., Brock M.J. A method for the rapid determination of Alkaline Phosphatase with five cubic mililitres of serum. J. Biol. Chem. 1946;164:321–338. [PubMed] [Google Scholar]
  • 19.Kaul S., Kapoor N.K. Sracolemma membrane enzyme changes in myocardial necrosis induced by isoproterenol and salvage by drugs. In: kidwai A.M., Uprett R.K, Roy P.K., editors. Biomembrane in health and disease. New Delhi, India: Today & Tomorrow Printer; 1991. pp. 439–439. [Google Scholar]
  • 20.Kaul S., Kapoor N.K. Reversal of changes of lipid peroxide, xanthine oxidase and superoxide dismutase by cardioprotective drugs in isoproterenol induced myocardial necrosis in rats. Indian. J. Exp. Biol. 1989;27:625–627. [PubMed] [Google Scholar]
  • 21.Havel R.J., Edel H.A., Bradgen J.A. The distribution and chemical composition of ultra centrifuge separated lipoproteins in human serum. J. Clin. Invest. 1955;34:1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Thomas P.A., Devasagam S., Tarachand U. Decrease lipid peroxidation in rat kidney during gestation. Biochem Biophys. Res. Comm. 1987;145:134–145. doi: 10.1016/0006-291X(87)91550-6. [DOI] [PubMed] [Google Scholar]
  • 23.McCord J.M., Fridovich I. Superoxide dismutase an enzyme functions for erythrocuprin (Hemocuprin) J. Biol Chem. 1969;244:6049–6055. [PubMed] [Google Scholar]
  • 24.Halliwal B., Gutteridge J.M.C., Arouma O.I. The deoxyribose method: A simple test tube assay for determination of rate constants for reaction OH. Anal. Biochem. 1987;165:215–219. doi: 10.1016/0003-2697(87)90222-3. [DOI] [PubMed] [Google Scholar]
  • 25.Bergstrom K, Sawa U. Improved diagnosis of acute myocardial infarction by frequint serum enzyme determinations. Acta Med. Scand. 1973;193:515–523. doi: 10.1111/j.0954-6820.1973.tb10619.x. [DOI] [PubMed] [Google Scholar]
  • 26.Okinaka S., Kumogai H., Ebashi S., Sugita H., Momoi H., Toyukura Y., Fuji S. Serum creatine phosphokinase activity in progressive muscular dystrophy and neuromuscular diseases. J. Biol. Chem. 1961;4:520–525. doi: 10.1001/archneur.1961.00450110050006. [DOI] [PubMed] [Google Scholar]
  • 27.Braunawald E. Mechanisms of calcium channel blocking agents. New Engl. J. Med. 1982;307:1618–1627. doi: 10.1056/NEJM198212233072605. [DOI] [PubMed] [Google Scholar]
  • 28.Srivastava L. M., Ganguli P. K. Metabolic intervention of heart attacks. Science. Reporter. 1981;July:318–327. [Google Scholar]
  • 29.McCord J.M. Oxygen derived radicals; A line between reperfusion injury and inflammation. Fed. Proc. 1987;46:2402–2412. [PubMed] [Google Scholar]
  • 30.Singh K., Chander R., Kapoor N.K. Guggulsterone a potent hypolipdemic, prevent oxidation of low-density protein. Phytotherapy Res. 1977;11:291–294. doi: 10.1002/(SICI)1099-1573(199706)11:4<291::AID-PTR96>3.0.CO;2-R. [DOI] [Google Scholar]
  • 31.McCord, P. J., Corey G D., Dorogi, P.L., Bajor, J.S., Knaggs, H. E., Lange, B.A., Sharpe, E. Anti sebum and antioxidant compositions containing guggulipid and alcoholic fraction thereof (1997). U. S. Patent No. 5, 690–948.
  • 32.Tripathy, Y.B., Malhotra, O.P. and Tripathy, S.N. (1985) Thyroid-stimulating actions of (Z) guggulsterone obtained fromCommiphora mukul. Planta Medica. 78–80. [DOI] [PubMed]
  • 33.Tripathy, Y.B., Tripathy, P., Malhotra, O.P. and Tripathy, S.N. (1988) Thyroid stimulating action of (Z) guggulsterone. Mechanism of action. Planta Medica 271–276. [DOI] [PubMed]
  • 34.Srivastava M., Kapoor N.K. Guggulsterone induced changes in the levels of biogenic monoamines and dopamine-β-hydroxylase activity in rat tissues. J. Biosci. 1988;10:15–19. doi: 10.1007/BF02702835. [DOI] [Google Scholar]
  • 35.Wu J., Xia C., Meier J., Li S., Hu X., LaLa D. D. The hypolipidemic natural product Guggulsterone acts as an antagonist of the bile acid receptor. Mol. Endocrinol. 2002;16:1590–1597. doi: 10.1210/me.16.7.1590. [DOI] [PubMed] [Google Scholar]
  • 36.Urizar N. L., Liverman A. B., Dodds D.N.T., Silva F.V., Ordentlich P., Yan Y., Gonzzalez F.J., Heyaman R.A., Mangelsdorf D.J., Moore D.D. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science. 2002;296:1703–1706. doi: 10.1126/science.1072891. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES